W W Grainger Inc vs Eli Lilly And Co — how do they compare? W W Grainger Inc trades at $1,388.97 (market cap $64.75B), while Eli Lilly And Co trades at $1,176.19 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 15.9× W W Grainger Inc's market cap, and W W Grainger Inc pays the higher dividend (0.68%). Which is the better fit depends on your goals.
| GWW | LLY | |
|---|---|---|
Market Cap | $64.75B | $1.03T |
Sector | Technology | Health |
52-Week High | $1.39K | $1.24K |
52-Week Low | $918.18 | $625.65 |
Enterprise Value | $66.84B | $1.07T |
Dividend Yield | 0.68% | 0.6% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,176.75, up 1.95% on the day, with strong fundamentals including a 31.66% net margin and consistent earnings beats. The stock shows a bearish technical signal near resistance at $1,177, while recent news highlights the $2.8 billion acquisition of AtaiBeckley to expand its mental health pipeline. Operating cash flow surged to $16.81 billion in 2025, supporting growth initiatives in obesity and Alzheimer's treatments.
Outlook remains positive with a $1.38K analyst price target and 73% buy ratings, but risks include competitive pressure in obesity drugs and high valuation multiples. Revenue growth of 65% in 2025 underscores momentum, though debt levels and acquisition integration pose challenges for sustained outperformance.
Trailing returns across standard periods
Latest headlines on both assets
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →